Oncology & Cancer

No therapy for 20 percent with stage IV solid tumors

(HealthDay) -- About 20 percent of patients diagnosed with stage IV metastatic solid tumors do not receive anticancer treatment, according to a study published online June 15 in Cancer.

Medical research

Diabetes and cancer: A shared biological basis

Contrary to what you might think, cancer and diabetes appear to have some biology in common. According to a report in the September 30th issue of the Cell Press journal, Cell, a pathway that initially drew attention for its ...

Oncology & Cancer

Small molecules shed light on cancer therapies

Patients suffering from an aggressive brain cancer will benefit from the results of a University of Illinois study that could advance the development of targeted gene therapies and improve prognosis.

page 16 from 18